Prospects for the Use of Genome-Editing Technology to Correct Neurodegenerative Diseases
- Autores: Stepanichev M.1
-
Afiliações:
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
- Edição: Volume 9, Nº 2 (2019)
- Páginas: 154-163
- Seção: Article
- URL: https://journals.rcsi.science/2079-0570/article/view/206347
- DOI: https://doi.org/10.1134/S2079057019020218
- ID: 206347
Citar
Resumo
The review analyzes the results of modern studies that involve gene therapy methods for the correction of neurodegenerative diseases. Approaches based on gene-editing technologies and their prospective use in medicine are considered. There may be limitations to the use of the genome-editing tools in the treatment of these pathologies due to features of the pathogenesis of neurodegenerative diseases.
Palavras-chave
Sobre autores
M. Stepanichev
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Autor responsável pela correspondência
Email: m_step_68@mail.ru
Rússia, Moscow, 117485